OBJECTIVE: To investigate outbreaks of multidrug-resistant tuberculosis (TB) by using DNA fingerprint databases. DESIGN: Investigation of two outbreaks of multidrug-resistant TB in separate hospitals in Spain by restriction fragment length polymorphism (RFLP) and spoligotyping. Outbreak strains were compared with more than 1500 RFLPs of Mycobacterium tuberculosis complex strains isolated in Spain and 6000 RFLPs from 30 different countries. METHODS: Standardized IS6110 DNA fingerprinting and 'spoligotyping' was used to type multidrug-resistant isolates belonging to the M. tuberculosis complex amongst the outbreak cases. The DNA types were matched against DNA fingerprint databases in Spain and The Netherlands. RESULTS: The DNA typing analysis indicated that a single multidrug-resistant Mycobacterium bovis strain was responsible for a nosocomial outbreak in a hospital in Spain involving at least 16 HIV-infected patients with non-treatable to multidrug-resistant TB. Introduction of the fingerprint type of this strain to the international database revealed a single matching strain. This strain was also isolated from an HIV-infected patient in The Netherlands who had died from multidrug-resistant TB. This patient had previously been hospitalized in Spain, where a multidrug-resistant TB nosocomial outbreak involving 20 HIV-infected patients was ongoing. The strains causing this outbreak were also identified as M. bovis with an identical DNA pattern to those strains isolated in the Spanish hospital and the patient in The Netherlands. CONCLUSIONS: The use of centralized DNA databases can help to identify rapidly the origin and transmission routes of multidrug-resistant TB across international boundaries and the potential use of such an early warning surveillance system for investigation of nosocomial multidrug-resistant TB outbreaks between HIV-infected patients. To our knowledge this is the first report of transmission of multidrug-resistant M. bovis between hospitals.
OBJECTIVE: To investigate outbreaks of multidrug-resistant tuberculosis (TB) by using DNA fingerprint databases. DESIGN: Investigation of two outbreaks of multidrug-resistant TB in separate hospitals in Spain by restriction fragment length polymorphism (RFLP) and spoligotyping. Outbreak strains were compared with more than 1500 RFLPs of Mycobacterium tuberculosis complex strains isolated in Spain and 6000 RFLPs from 30 different countries. METHODS: Standardized IS6110 DNA fingerprinting and 'spoligotyping' was used to type multidrug-resistant isolates belonging to the M. tuberculosis complex amongst the outbreak cases. The DNA types were matched against DNA fingerprint databases in Spain and The Netherlands. RESULTS: The DNA typing analysis indicated that a single multidrug-resistant Mycobacterium bovis strain was responsible for a nosocomial outbreak in a hospital in Spain involving at least 16 HIV-infectedpatients with non-treatable to multidrug-resistant TB. Introduction of the fingerprint type of this strain to the international database revealed a single matching strain. This strain was also isolated from an HIV-infectedpatient in The Netherlands who had died from multidrug-resistant TB. This patient had previously been hospitalized in Spain, where a multidrug-resistant TB nosocomial outbreak involving 20 HIV-infectedpatients was ongoing. The strains causing this outbreak were also identified as M. bovis with an identical DNA pattern to those strains isolated in the Spanish hospital and the patient in The Netherlands. CONCLUSIONS: The use of centralized DNA databases can help to identify rapidly the origin and transmission routes of multidrug-resistant TB across international boundaries and the potential use of such an early warning surveillance system for investigation of nosocomial multidrug-resistant TB outbreaks between HIV-infectedpatients. To our knowledge this is the first report of transmission of multidrug-resistant M. bovis between hospitals.
Authors: S Samper; M J Iglesias; M J Rabanaque; L I Gómez; M C Lafoz; M S Jiménez; A Ortega; M A Lezcano; D Van Soolingen; C Martín Journal: J Clin Microbiol Date: 2005-03 Impact factor: 5.948
Authors: Timothy C Rodwell; Anokhi J Kapasi; Marisa Moore; Feliciano Milian-Suazo; Beth Harris; L P Guerrero; Kathleen Moser; Steffanie A Strathdee; Richard S Garfein Journal: Int J Infect Dis Date: 2010-04-18 Impact factor: 3.623
Authors: M J Zumárraga; C Martin; S Samper; A Alito; O Latini; F Bigi; E Roxo; M E Cicuta; F Errico; M C Ramos; A Cataldi; D van Soolingen; M I Romano Journal: J Clin Microbiol Date: 1999-02 Impact factor: 5.948
Authors: Marcio Roberto Silva; Adalgiza da Silva Rocha; Ronaldo Rodrigues da Costa; Andrea Padilha de Alencar; Vania Maria de Oliveira; Antônio Augusto Fonseca Júnior; Mariana Lázaro Sales; Marina de Azevedo Issa; Paulo Martins Soares Filho; Omara Tereza Vianello Pereira; Eduardo Calazans dos Santos; Rejane Silva Mendes; Angela Maria de Jesus Ferreira; Pedro Moacyr Pinto Coelho Mota; Philip Noel Suffys; Mark Drew Crosland Guimarães Journal: Mem Inst Oswaldo Cruz Date: 2013-05 Impact factor: 2.743
Authors: H Maguire; J W Dale; T D McHugh; P D Butcher; S H Gillespie; A Costetsos; H Al-Ghusein; R Holland; A Dickens; L Marston; P Wilson; R Pitman; D Strachan; F A Drobniewski; D K Banerjee Journal: Thorax Date: 2002-07 Impact factor: 9.139